-The Times of India NEW DELHI: A close scrutiny of the accounts of the Bihar government shouldn't surprise you about the midday meal (MDM) tragedy that claimed the lives of more than 20 children last week. To make matters worse, there were serious infrastructure inadequacies in government hospitals meant to treat children who had taken ill. The level of Bihar government's lethargy and callousness is far more serious than what is known...
More »SEARCH RESULT
India’s dysfunctional public health system
-Live Mint The country is a happy hunting ground for communicable diseases In a Mint article last week, economist Dean Spears pointed out that the double whammy of high population density and unsanitary conditions in India stunts the growth of children, who bear a disproportionate burden of infectious diseases and lose their ability to absorb nutrients. Unless India ramps up its public health system, providing extra food will mean little for...
More »The right medicine
-The Business Standard Govt should streamline its free medicines plan The Centre is reportedly going to shelve a plan to procure generic drugs for free supply to patients throughout the country. This is a serious error. Reportedly, states will instead be asked to do so; but, if a perceived inability to procure, stock and distribute these drugs is the reason for backtracking on the plan, how precisely will states be free of...
More »Social Justice
KEY TRENDS • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8 • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...
More »SC’s Novartis judgement renews focus on accessible medicine
The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...
More »